Back to Trades
Other4
Seaport Therapeutics, Inc.
SPTX
Total Value
$0
Company Information
- Company Name
- Seaport Therapeutics, Inc.
- Ticker Symbol
- SPTX
- CIK
- 0002042347
Insider Information
- Role
- Insider
- Location
- BOSTON, MA
Filing Details
- Filing Date
- May 6, 2026
- Transaction Date
- May 4, 2026
- Accession Number
- 0001193125-26-209701
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| May 4, 2026 | Common Stock | 12,736,014 | — | C | — |
| May 4, 2026 | Common Stock | 2,681,265 | — | C | — |
| May 4, 2026 | Common Stock | 965,255 | — | C | — |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| May 4, 2026 | Derivative | 40,000,000 | — | C | — |
| May 4, 2026 | Derivative | 8,421,052 | — | C | — |
| May 4, 2026 | Derivative | 3,031,578 | — | C | — |
Footnotes
- (F1)Each share of Series A-1, Series A-2 and Series B Preferred Stock (collectively, the "Preferred Stock") was convertible into Common Stock of the Issuer on a one-for-3.1407 basis at the option of the holder, and automatically converted upon the closing of the Issuer's initial public offering without payment of further consideration. The Preferred Stock had no expiration date.
- (F2)PureTech LYT, Inc. is the record holder of all of the securities reported in this Form 4. PureTech Health LLC is the sole owner of PureTech LYT, Inc. PureTech Health plc is the sole member of PureTech Health LLC, and has the power to direct the voting and disposition of securities held by PureTech LYT, Inc. and PureTech Health LLC.